GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 5951 |
VCM
Vivaldi Capital Management
Chicago,
Illinois
| $0 | -$25.8M | 0 | – | Closed |
|
| 5952 |
VA
VR Adviser
New York
| $0 | -$12.2M | 0 | – | Closed |
|
| 5953 |
WAM
Warberg Asset Management
Winnetka,
Illinois
| $0 | -$40.4K | 0 | – | Closed |
|
| 5954 |
WPA
Wealth Preservation Advisors
Chattanooga,
Tennessee
| $0 | -$352K | 0 | – | Closed |
|
| 5955 |
WCA
Whetstone Capital Advisors
Shawnee Mission,
Kansas
| $0 | -$1.3M | 0 | – | Closed |
|
| 5956 |
WWP
Wise Wealth Partners
Phoenix,
Arizona
| $0 | -$694K | 0 | – | Closed |
|
| 5957 |
WC
Wolfstich Capital
Medfield,
Massachusetts
| $0 | -$233K | 0 | – | Closed |
|